Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4ICL3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 141 | 145 | PF00656 | 0.504 |
CLV_C14_Caspase3-7 | 205 | 209 | PF00656 | 0.619 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.460 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.668 |
CLV_PCSK_SKI1_1 | 60 | 64 | PF00082 | 0.488 |
DEG_SPOP_SBC_1 | 191 | 195 | PF00917 | 0.655 |
DEG_SPOP_SBC_1 | 9 | 13 | PF00917 | 0.627 |
DOC_USP7_MATH_1 | 107 | 111 | PF00917 | 0.500 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.698 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.651 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.733 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.587 |
LIG_14-3-3_CanoR_1 | 188 | 196 | PF00244 | 0.728 |
LIG_14-3-3_CanoR_1 | 245 | 250 | PF00244 | 0.617 |
LIG_14-3-3_CanoR_1 | 7 | 16 | PF00244 | 0.590 |
LIG_14-3-3_CanoR_1 | 82 | 88 | PF00244 | 0.521 |
LIG_14-3-3_CanoR_1 | 91 | 97 | PF00244 | 0.459 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.667 |
LIG_BRCT_BRCA1_1 | 151 | 155 | PF00533 | 0.495 |
LIG_DLG_GKlike_1 | 245 | 253 | PF00625 | 0.505 |
LIG_FHA_1 | 191 | 197 | PF00498 | 0.586 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.438 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.608 |
LIG_FHA_1 | 99 | 105 | PF00498 | 0.445 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.698 |
LIG_FHA_2 | 193 | 199 | PF00498 | 0.605 |
LIG_FHA_2 | 218 | 224 | PF00498 | 0.522 |
LIG_LIR_Gen_1 | 131 | 140 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 167 | 175 | PF02991 | 0.545 |
LIG_LIR_Gen_1 | 85 | 93 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 131 | 137 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 167 | 172 | PF02991 | 0.574 |
LIG_LIR_Nem_3 | 220 | 225 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 85 | 90 | PF02991 | 0.504 |
LIG_PCNA_PIPBox_1 | 112 | 121 | PF02747 | 0.510 |
LIG_PCNA_PIPBox_1 | 240 | 249 | PF02747 | 0.643 |
LIG_PCNA_yPIPBox_3 | 240 | 250 | PF02747 | 0.636 |
LIG_SH2_CRK | 222 | 226 | PF00017 | 0.507 |
LIG_SH2_NCK_1 | 146 | 150 | PF00017 | 0.367 |
LIG_SH2_STAP1 | 146 | 150 | PF00017 | 0.367 |
LIG_SH2_STAP1 | 247 | 251 | PF00017 | 0.514 |
LIG_SH2_STAP1 | 57 | 61 | PF00017 | 0.537 |
LIG_SH2_STAT3 | 19 | 22 | PF00017 | 0.595 |
LIG_SH2_STAT3 | 237 | 240 | PF00017 | 0.596 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.512 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.488 |
LIG_SUMO_SIM_anti_2 | 208 | 216 | PF11976 | 0.472 |
LIG_TYR_ITSM | 218 | 225 | PF00017 | 0.512 |
MOD_CDK_SPK_2 | 2 | 7 | PF00069 | 0.573 |
MOD_CDK_SPxxK_3 | 181 | 188 | PF00069 | 0.621 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.549 |
MOD_CK1_1 | 190 | 196 | PF00069 | 0.601 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.464 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.604 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.554 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.690 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.477 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.656 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.684 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.489 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.628 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.462 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.646 |
MOD_GSK3_1 | 202 | 209 | PF00069 | 0.579 |
MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.550 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.662 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.335 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.502 |
MOD_NEK2_1 | 229 | 234 | PF00069 | 0.409 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.456 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.420 |
MOD_NEK2_2 | 168 | 173 | PF00069 | 0.645 |
MOD_NEK2_2 | 45 | 50 | PF00069 | 0.495 |
MOD_NEK2_2 | 55 | 60 | PF00069 | 0.353 |
MOD_PIKK_1 | 179 | 185 | PF00454 | 0.736 |
MOD_PIKK_1 | 92 | 98 | PF00454 | 0.545 |
MOD_PKA_2 | 187 | 193 | PF00069 | 0.757 |
MOD_PKB_1 | 80 | 88 | PF00069 | 0.484 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.559 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.443 |
MOD_Plk_4 | 229 | 235 | PF00069 | 0.406 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.497 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.732 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.585 |
TRG_AP2beta_CARGO_1 | 167 | 176 | PF09066 | 0.549 |
TRG_DiLeu_BaEn_1 | 210 | 215 | PF01217 | 0.579 |
TRG_DiLeu_BaLyEn_6 | 57 | 62 | PF01217 | 0.482 |
TRG_ENDOCYTIC_2 | 222 | 225 | PF00928 | 0.503 |
TRG_ENDOCYTIC_2 | 246 | 249 | PF00928 | 0.544 |
TRG_Pf-PMV_PEXEL_1 | 60 | 64 | PF00026 | 0.531 |
TRG_Pf-PMV_PEXEL_1 | 91 | 96 | PF00026 | 0.530 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDB2 | Leptomonas seymouri | 51% | 91% |
A0A0S4JAI8 | Bodo saltans | 31% | 100% |
A0A1X0P886 | Trypanosomatidae | 37% | 100% |
A0A3S7XAI3 | Leishmania donovani | 100% | 100% |
D0A2U7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9ASP1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4Q1V5 | Leishmania major | 85% | 100% |
V5B9R5 | Trypanosoma cruzi | 36% | 100% |